Works by Sriuranpong, Virote


Results: 48
    1
    2
    3

    Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 83, doi. 10.4143/crt.2021.1571
    By:
    • Byoung Chul Cho;
    • Dong-Wan Kim;
    • Ullas Batra;
    • Keunchil Park;
    • Sang-We Kim;
    • Cheng-Ta Yang;
    • Pei-Jye Voon;
    • Virote Sriuranpong;
    • K. Govind Babu;
    • Khalid Amin;
    • Yingbo Wang;
    • Paramita Sen;
    • Khemaies Slimane;
    • Sarayut Geater
    Publication type:
    Article
    4

    The treatment landscape of advanced angiosarcoma in Asia—A multi‐national collaboration from the Asian Sarcoma Consortium.

    Published in:
    Cancer Science, 2021, v. 112, n. 3, p. 1095, doi. 10.1111/cas.14793
    By:
    • Chen, Tom Wei‐Wu;
    • Pang, Angela;
    • Puhaindran, Mark E.;
    • Maw, Myo Myint;
    • Loong, Herbert H.;
    • Sriuranpong, Virote;
    • Chang, Chih‐Chi;
    • Mingmalairak, Siyamol;
    • Hirose, Takeshi;
    • Endo, Makoto;
    • Kawai, Akira;
    • Farid, Mohamad;
    • Tan, Sze Huey;
    • Goh, Wei Lin;
    • Quek, Richard;
    • Chan, Jeffrey C. H.;
    • Leung, Alex K. C.;
    • Ngan, Roger K. C.
    Publication type:
    Article
    5
    6
    7
    8
    9

    Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment.

    Published in:
    Vaccines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/vaccines10101662
    By:
    • Wanchaijiraboon, Passakorn;
    • Teeyapun, Nattaya;
    • Pakvisal, Nussara;
    • Sainamthip, Panot;
    • Susiriwatananont, Thiti;
    • Zungsontiporn, Nicha;
    • Suntronwong, Nungruthai;
    • Vichaiwattana, Preeyaporn;
    • Klinsawat, Worata;
    • Wanlapakorn, Nasamon;
    • Tanasanvimon, Suebpong;
    • Sriuranpong, Virote;
    • Poovorawan, Yong;
    • Luangdilok, Sutima
    Publication type:
    Article
    10

    Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine.

    Published in:
    Vaccines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/vaccines10101613
    By:
    • Luangdilok, Sutima;
    • Wanchaijiraboon, Passakorn;
    • Pakvisal, Nussara;
    • Susiriwatananont, Thiti;
    • Zungsontiporn, Nicha;
    • Sriuranpong, Virote;
    • Sainamthip, Panot;
    • Suntronwong, Nungruthai;
    • Vichaiwattana, Preeyaporn;
    • Wanlapakorn, Nasamon;
    • Poovorawan, Yong;
    • Teeyapun, Nattaya;
    • Tanasanvimon, Suebpong
    Publication type:
    Article
    11
    12
    13

    Cemiplimab monotherapy as first‐line treatment of patients with brain metastases from advanced non–small cell lung cancer with programmed cell death‐ligand 1 ≥50%.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 10, p. 1, doi. 10.1002/cncr.35864
    By:
    • Kilickap, Saadettin;
    • Özgüroğlu, Mustafa;
    • Sezer, Ahmet;
    • Gümüş, Mahmut;
    • Bondarenko, Igor;
    • Gogishvili, Miranda;
    • Turk, Haci M.;
    • Cicin, Irfan;
    • Bentsion, Dmitry;
    • Gladkov, Oleg;
    • Sriuranpong, Virote;
    • Quek, Ruben G. W.;
    • McIntyre, Debra A. G.;
    • He, Xuanyao;
    • McGinniss, Jennifer;
    • Seebach, Frank;
    • Gullo, Giuseppe;
    • Rietschel, Petra;
    • Pouliot, Jean‐Francois
    Publication type:
    Article
    14
    15

    The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 2, p. 396, doi. 10.1007/s10147-019-01570-3
    By:
    • Vimolchalao, Veerisa;
    • Sakdejayont, Siwat;
    • Wongchanapai, Ploytuangporn;
    • Sukprakun, Shama;
    • Angspatt, Pattama;
    • Thawinwisan, Wilai;
    • Chenaksara, Piyachut;
    • Sriuranpong, Virote;
    • Vinayanuwatikun, Chanida;
    • Parinyanitikun, Napa;
    • Poovorawan, Nattaya;
    • Tanasanvimon, Suebpong
    Publication type:
    Article
    16
    17
    18

    Long-term impact of anthracycline in early-stage breast cancer, bridging of MiRNAs profiler for early cardiotoxicity.

    Published in:
    Cardio-Oncology, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40959-025-00337-2
    By:
    • Poovorawan, Nattaya;
    • Susiriwatananont, Thiti;
    • Teerapakpinyo, Chinachote;
    • Chariyavilaskul, Pajaree;
    • Sitthideatphaiboon, Piyada;
    • Jarutasnangkul, Luxica;
    • Tumkosit, Monravee;
    • Chattranukulchai, Pairoj;
    • Theerasuwipakorn, Nonthikorn;
    • Aporntewan, Chatchawit;
    • Shuangshoti, Shanop;
    • Manasnayakorn, Sopark;
    • Vinayanuwattikun, Chanida;
    • Vorasettakarnkij, Yongkasem;
    • Sriuranpong, Virote
    Publication type:
    Article
    19

    Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls.

    Published in:
    Human Vaccines & Immunotherapeutics, 2022, v. 18, n. 6, p. 1, doi. 10.1080/21645515.2022.2094149
    By:
    • Pakvisal, Nussara;
    • Sainamthip, Panot;
    • Teeyapun, Nattaya;
    • Luangdilok, Sutima;
    • Wanlapakorn, Nassamon;
    • Yorsaeng, Ritthideach;
    • Poovorawan, Yong;
    • Pakvisal, Piyapoom;
    • Susiriwatananont, Thiti;
    • Zungsontiporn, Nicha;
    • Sriuranpong, Virote;
    • Tanasanvimon, Suebpong;
    • Wanchaijiraboon, Passakorn
    Publication type:
    Article
    20

    A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919889001
    By:
    • Qin, Shukui;
    • Chan, Stephen Lam;
    • Sukeepaisarnjaroen, Wattana;
    • Han, Guohong;
    • Choo, Su Pin;
    • Sriuranpong, Virote;
    • Pan, Hongming;
    • Yau, Thomas;
    • Guo, Yabing;
    • Chen, Minshan;
    • Ren, Zhenggang;
    • Xu, Jianming;
    • Yen, Chia-Jui;
    • Lin, Zhong-Zhe;
    • Manenti, Luigi;
    • Gu, Yi;
    • Sun, Yongjian;
    • Tiedt, Ralph;
    • Hao, Lu;
    • Song, Wenjie
    Publication type:
    Article
    21
    22

    Sunrise in melanoma management: Time to focus on melanoma burden in Asia.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 6, p. 423, doi. 10.1111/ajco.12670
    By:
    • Chang, John Wen‐Cheng;
    • Guo, Jun;
    • Hung, Chia‐Yen;
    • Lu, Si;
    • Shin, Sang Joon;
    • Quek, Richard;
    • Ying, Anthony;
    • Ho, Gwo Fuang;
    • Nguyen, Huu Sau;
    • Dhabhar, Boman;
    • Sriuranpong, Virote;
    • Tiambeng, Maria Luisa;
    • Prayogo, Nugroho;
    • Yamazaki, Naoya
    Publication type:
    Article
    23
    24
    25
    26

    Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2011, v. 7, p. 4, doi. 10.1111/j.1743-7563.2011.01397.x
    By:
    • MOK, Tony S. K.;
    • Te-Chun HSIA;
    • Chun-Ming TSAI;
    • TSANG, Kenneth;
    • Gee-Chen CHANG;
    • Wen-Cheng CHANG, John;
    • THITIYA, Sirisinha;
    • SRIURANPONG, Virote;
    • THONGPRASERT, Sumitra;
    • CHUA, Daniel T. T.;
    • MOORE, Nicola;
    • MANEGOLD, Christian
    Publication type:
    Article
    27
    28
    29
    30
    31
    32

    Adaptation of International Guidelines for Metastatic Colorectal Cancer: An Asian Consensus.

    Published in:
    Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 145, doi. 10.1016/j.clcc.2014.06.004
    By:
    • Ann-Lii Cheng;
    • Jin Li;
    • Vaid, Ashok K.;
    • Buig Yue Ma, Brigette;
    • Teh, Catherine;
    • Joong B. Ahn;
    • Bello, Maximino;
    • Chaiyut Charoentum;
    • Li-Tzong Chen;
    • de Lima Lopes, Gilberto;
    • Gwo F. Ho;
    • Hwai L. Kong;
    • Ka O. Lam;
    • Tian S. Liu;
    • Young S. Park;
    • Virote Sriuranpong;
    • Sudoyo, Aru W.;
    • Jaw-Yuan Wang;
    • Jun Zhang;
    • Su Z. Zhang
    Publication type:
    Article
    33
    34

    A new era of the Asian clinical research network: a report from the ATLAS international symposium.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 619, doi. 10.1093/jjco/hyad033
    By:
    • Terada, Mitsumi;
    • Nakamura, Kenichi;
    • Matsuda, Tomohiro;
    • Okuma, Hitomi Sumiyoshi;
    • Sudo, Kazuki;
    • Yusof, Akhmal;
    • Imasa, Marcelo;
    • Sirachainan, Ekaphop;
    • Anh, Pham Tuan;
    • Fujiwara, Yasuhiro;
    • Yamamoto, Noboru;
    • Voon, Pei Jye;
    • Chokephaibulkit, Kulkanya;
    • Shibata, Tatsuhiro;
    • Inoue, Manami;
    • Mano, Hiroyuki;
    • Shimoi, Tatsunori;
    • Sriuranpong, Virote;
    • Yonemori, Kan;
    • Shimada, Kazuaki
    Publication type:
    Article
    35
    36
    37

    Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 841, doi. 10.1007/s10147-021-01869-0
    By:
    • Chang, Gee-Chen;
    • Lam, David Chi-Leung;
    • Tsai, Chun-Ming;
    • Chen, Yuh-Min;
    • Shih, Jin-Yuan;
    • Aggarwal, Shyam;
    • Wang, Shuhang;
    • Kim, Sang-We;
    • Kim, Young-Chul;
    • Wahid, Ibrahim;
    • Li, Rubi;
    • Lim, Darren Wan-Teck;
    • Sriuranpong, Virote;
    • Chan, Raymond Tsz-Tong;
    • Lorence, Robert M.;
    • Carriere, Philippe;
    • Raabe, Christina;
    • Cseh, Agnieszka;
    • Park, Keunchil
    Publication type:
    Article
    38
    39
    40

    Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC).

    Published in:
    BioDrugs, 2021, v. 35, n. 4, p. 417, doi. 10.1007/s40259-021-00489-4
    By:
    • Syrigos, Konstantinos;
    • Abert, Istvan;
    • Andric, Zoran;
    • Bondarenko, Igor N;
    • Dvorkin, Mikhail;
    • Galic, Kristina;
    • Galiulin, Rinat;
    • Kuchava, Vladimer;
    • Sriuranpong, Virote;
    • Trukhin, Dmytro;
    • Zhavrid, Edvard;
    • Fu, Dongyue;
    • Kassalow, Laurent M;
    • Jones, Stephanie;
    • Bashir, Zahid
    Publication type:
    Article
    41

    Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.

    Published in:
    2017
    By:
    • Rugo, Hope S.;
    • Barve, Abhijit;
    • Waller, Cornelius F.;
    • Hernandez-Bronchud, Miguel;
    • Herson, Jay;
    • Jinyu Yuan;
    • Sharma, Rajiv;
    • Baczkowski, Mark;
    • Kothekar, Mudgal;
    • Loganathan, Subramanian;
    • Manikhas, Alexey;
    • Bondarenko, Igor;
    • Mukhametshina, Guzel;
    • Nemsadze, Gia;
    • Parra, Joseph D.;
    • Abesamis-Tiambeng, Maria Luisa T.;
    • Baramidze, Kakhaber;
    • Akewanlop, Charuwan;
    • Sriuranpong, Virote;
    • Mamillapalli, Gopichand
    Publication type:
    journal article
    42
    43

    Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.

    Published in:
    Lung Cancer: Targets & Therapy, 2024, v. 15, p. 87, doi. 10.2147/LCTT.S463429
    By:
    • Ou, Sai-Hong Ignatius;
    • Le, Xiuning;
    • Nagasaka, Misako;
    • Reungwetwattana, Thanyanan;
    • Ahn, Myung-Ju;
    • Lim, Darren WT;
    • Santos, Edgardo S;
    • Shum, Elaine;
    • Lau, Sally CM;
    • Lee, Jii Bum;
    • Calles, Antonio;
    • Wu, Fengying;
    • Lopes, Gilberto;
    • Sriuranpong, Virote;
    • Tanizaki, Junko;
    • Horinouchi, Hidehito;
    • Garassino, Marina C;
    • Popat, Sanjay;
    • Besse, Benjamin;
    • Rosell, Rafael
    Publication type:
    Article
    44

    KEYNOTE‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive, advanced NSCLC.

    Published in:
    International Journal of Cancer, 2023, v. 153, n. 3, p. 623, doi. 10.1002/ijc.34532
    By:
    • Ren, Shengxiang;
    • Feng, Jifeng;
    • Ma, Shenglin;
    • Chen, HuaJun;
    • Ma, Zhiyong;
    • Huang, Cheng;
    • Zhang, Li;
    • He, Jianxing;
    • Wang, Changli;
    • Zhou, Jianying;
    • Danchaivijtr, Pongwut;
    • Wang, Chin‐Chou;
    • Vynnychenko, Ihor;
    • Wang, Kai;
    • Orlandi, Francisco;
    • Sriuranpong, Virote;
    • Li, Ben;
    • Ge, Jun;
    • Dang, Thao;
    • Zhou, Caicun
    Publication type:
    Article
    45

    Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2021, v. 188, n. 2, p. 369, doi. 10.1007/s10549-021-06197-5
    By:
    • Rugo, Hope S.;
    • Pennella, Eduardo J.;
    • Gopalakrishnan, Unmesh;
    • Hernandez-Bronchud, Miguel;
    • Herson, Jay;
    • Koch, Hans Friedrich;
    • Loganathan, Subramanian;
    • Deodhar, Sarika;
    • Marwah, Ashwani;
    • Manikhas, Alexey;
    • Bondarenko, Igor;
    • Mukhametshina, Guzel;
    • Nemsadze, Gia;
    • Parra, Joseph D.;
    • Abesamis-Tiambeng, Maria Luisa T.;
    • Baramidze, Kakhaber;
    • Akewanlop, Charuwan;
    • Vynnychenko, Ihor;
    • Sriuranpong, Virote;
    • Mamillapalli, Gopichand
    Publication type:
    Article
    46
    47

    Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-06239-y
    By:
    • Sitthideatphaiboon, Piyada;
    • Teerapakpinyo, Chinachote;
    • Korphaisarn, Krittiya;
    • Leelayuwatanakul, Nophol;
    • Pornpatrananrak, Nopporn;
    • Poungvarin, Naravat;
    • Chantranuwat, Poonchavist;
    • Shuangshoti, Shanop;
    • Aporntewan, Chatchawit;
    • Chintanapakdee, Wariya;
    • Sriuranpong, Virote;
    • Vinayanuwattikun, Chanida
    Publication type:
    Article
    48